These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9002013)

  • 1. Antiphospholipid antibodies in patients with eosinophilia myalgia and toxic oil syndrome.
    Carreira PE; Montalvo MG; Kaufman LD; Silver RM; Izquierdo M; Gomez-Reino JJ
    J Rheumatol; 1997 Jan; 24(1):69-72. PubMed ID: 9002013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in tryptophan metabolism in the toxic oil syndrome and in the eosinophilia-myalgia syndrome.
    Silver RM; Sutherland SE; Carreira P; Heyes MP
    J Rheumatol; 1992 Jan; 19(1):69-73. PubMed ID: 1532618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophilia.
    Kaufman LD; Krupp LB
    Curr Opin Rheumatol; 1995 Nov; 7(6):560-7. PubMed ID: 8579979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Toxic oil syndrome--an example of an exogenously-induced autoimmune disease].
    Bell S; Brand K; Meurer M
    Hautarzt; 1992 Jun; 43(6):339-43. PubMed ID: 1628965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical analysis of lymphocytes in postmortem study of the heart from fatal cases of the eosinophilia myalgia syndrome and of the toxic oil syndrome.
    Hayashi T; James TN
    Am Heart J; 1994 May; 127(5):1298-308. PubMed ID: 8172059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biotransformation of 3-(phenylamino)-1,2-propanediol to 3-(phenylamino)alanine: a chemical link between toxic oil syndrome and eosinophilia-myalgia syndrome.
    Mayeno AN; Benson LM; Naylor S; Colberg-Beers M; Puchalski JT; Gleich GJ
    Chem Res Toxicol; 1995; 8(7):911-6. PubMed ID: 8555405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Eosinophilia myalgia syndrome (EMS) caused by L-tryptophan product and toxic oil syndrome (TOS) caused by denatured rape-seed oil].
    Maitani T; Saitoh H
    Shokuhin Eiseigaku Zasshi; 2009 Dec; 50(6):279-91. PubMed ID: 20065617
    [No Abstract]   [Full Text] [Related]  

  • 8. Generation of quinoneimine intermediates in the bioactivation of 3-(N-phenylamino)alanine (PAA) by human liver microsomes: a potential link between eosinophilia-myalgia syndrome and toxic oil syndrome.
    Martínez-Cabot A; Messeguer A
    Chem Res Toxicol; 2007 Oct; 20(10):1556-62. PubMed ID: 17892268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid HPLC screening method for contaminants found in implicated L-tryptophan associated with eosinophilia myalgia syndrome and adulterated rapeseed oil associated with toxic oil syndrome.
    Williamson BL; Tomlinson AJ; Hurth KM; Posada de la Paz M; Gleich GJ; Naylor S
    Biomed Chromatogr; 1998; 12(5):255-61. PubMed ID: 9787895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrogenic growth factors in the eosinophilia-myalgia syndrome and the toxic oil syndrome.
    Kaufman LD; Gruber BL; Gomez-Reino JJ; Miller F
    Arch Dermatol; 1994 Jan; 130(1):41-7. PubMed ID: 8285738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The toxic oil syndrome: 20 years on.
    Diggle GE
    Int J Clin Pract; 2001; 55(6):371-5. PubMed ID: 11501225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophilia.
    Silver RM
    Curr Opin Rheumatol; 1992 Dec; 4(6):851-6. PubMed ID: 1457280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine mRNA expression in lung tissue from toxic oil syndrome patients: a TH2 immunological mechanism.
    del Pozo V; de Andrés B; Gallardo S; Cárdaba B; de Arruda-Chaves E; Cortegano MI; Jurado A; Palomino P; Oliva H; Aguilera B; Posada M; Lahoz C
    Toxicology; 1997 Mar; 118(1):61-70. PubMed ID: 9074654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1995 Bailey K. Ashford lecture. Public health lessons from two catastrophic epidemics: the toxic oil syndrome and the eosinophilia-myalgia syndrome.
    James TN
    P R Health Sci J; 1996 Mar; 15(1):45-8. PubMed ID: 8744866
    [No Abstract]   [Full Text] [Related]  

  • 15. Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophilia.
    Silver RM
    Curr Opin Rheumatol; 1993 Nov; 5(6):802-8. PubMed ID: 8117543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features of eosinophilia myalgia syndrome and related disorders.
    Clauw DJ
    Adv Exp Med Biol; 1996; 398():331-8. PubMed ID: 8906285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The toxic oil syndrome (TOS, 1981): from the disease towards a toxicological understanding of its chemical aetiology and mechanism.
    Aldridge WN
    Toxicol Lett; 1992 Dec; 64-65 Spec No():59-70. PubMed ID: 1471212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Eosinophilia-myalgia: new syndrome].
    Szechiński J; Borysewicz K
    Postepy Hig Med Dosw; 1992; 46(3):319-25. PubMed ID: 1369828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study on antibodies to nucleoli and 5-hydroxytryptamine in patients with fibromyalgia syndrome and tryptophan-induced eosinophilia-myalgia syndrome.
    Klein R; Berg PA
    Clin Investig; 1994 Jul; 72(7):541-9. PubMed ID: 7981584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxic oil syndrome and eosinophilia myalgia syndrome: similar, different or the same disorder?
    Kaufman LD; Izquierdo Martinez M; Gomez-Reino JJ
    J Rheumatol; 1994 Dec; 21(12):2177-8. PubMed ID: 7699614
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.